Johnson & Johnson announced that it entered into a definitive agreement to acquire Atraverse Medical. Regeneron struck a drug pricing deal with the Trump administration to reduce prices on drugs for ...

Regulators consider end to compounding of GLP-1s; RFK Jr. appeals court decision blocking changes to vaccine schedule; FDA ...

Pharma marketing has fundamentally changed. Awareness, demand, education and access are no longer the winning plays.

Healthcare marketers know traditional channels, but what comes next?

There is little reputable evidence to back their claims. But health concerns have helped power a solar backlash that ...

Violence is never acceptable and any comments that suggest otherwise are in no way consistent with our mission and values,’ ...

A community healthcare worker is a “trusted member” of a local community or someone who has “an unusually close understanding ...

Bayer received an FDA Untitled Letter this week for its prostate cancer drug Nubeqa, shortly after it launched a lawsuit ...

This isn’t about polished answers or safe perspectives. It’s about what’s actually working in health, and what’s not.

O’Brien joined the publication in April 2022 as digital editor and has served as senior editor and managing editor over the ...

RareLabs, a division of AlphaRose Therapeutics, named Rob Freishtat, MD as CEO. Charles Hirner joined NuvemRx as SVP of ...

Generics battle takes center stage at SCOTUS; FDA uses AI for clinical trial review; Purdue Pharma to dissolve.